All Stories

  1. A vaccine tailored to subgroups of Type 1 diabetes patients for better efficacy.

    Article • Proceedings of the National Academy of Sciences, April 2022, Proceedings of the National Academy of Sciences

    Remi Creusot

  2. Soluble Antigen Arrays Efficiently Deliver Peptides and Arrest Spontaneous Autoimmune Diabetes

    Article • Diabetes, January 2021, American Diabetes Association

    Remi Creusot

  3. Altered Function of Antigen-Presenting Cells in Type 1 Diabetes: A Challenge for Antigen-Specific Immunotherapy?

    Article • Diabetes, July 2018, American Diabetes Association

    Remi Creusot